Evidence map›Paper›PMID 39462331›Full record

ArticleBMC psychiatry2024

The association between aberrant salience and psychotic experiences in general population twins, and genetic vulnerability as a modifier.

Marjan Drukker, Tatvan Todor, Jelle Bongaarts, Eleonora Broggi, Mihika Kelkar, Thomas Wigglesworth, Kayle Verhiel, Karel van Leeuwen, Meinte Koster, Catherine Derom and 10 more

Abstract readTwin Study
In one paragraph

Article in BMC psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Marjan DrukkerDepartment of Psychiatry and Neuropsychology, School of Mental Health and Neuroscience (MHeNS), Maastricht University Medical Centre, Maastricht, the Netherlands. Marjan.Drukker@MaastrichtUniversity.nl.ORCID 0000-0002-6346-2662
Tatvan TodorFaculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.
Jelle BongaartsFaculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.
Eleonora BroggiFaculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.ORCID 0009-0003-5520-7770
Mihika KelkarFaculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.
Thomas WigglesworthFaculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.
Kayle VerhielFaculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.
Karel van LeeuwenFaculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.
Meinte KosterFaculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.
Catherine DeromDepartment of Obstetrics and Gynecology, Ghent University Hospitals, Ghent University, Ghent, Belgium.
Evert ThieryDepartment of Neurology, Ghent University Hospital, Ghent University, Ghent, Belgium.
Marc De HertUniversity Psychiatric Centre, Katholieke Universiteit Leuven, Kortenberg, Belgium.
Claudia Menne-LothmannDepartment of Psychiatry and Neuropsychology, School of Mental Health and Neuroscience (MHeNS), Maastricht University Medical Centre, Maastricht, the Netherlands.
Jeroen DecosterPsychiatric Care Sint-Kamillus, Brothers of Charity, Bierbeek, Belgium.
Dina CollipDepartment of Psychiatry and Neuropsychology, School of Mental Health and Neuroscience (MHeNS), Maastricht University Medical Centre, Maastricht, the Netherlands.
Ruud van WinkelDepartment of Psychiatry and Neuropsychology, School of Mental Health and Neuroscience (MHeNS), Maastricht University Medical Centre, Maastricht, the Netherlands.
Nele JacobsDepartment of Psychiatry and Neuropsychology, School of Mental Health and Neuroscience (MHeNS), Maastricht University Medical Centre, Maastricht, the Netherlands.
Sinan GuloksuzDepartment of Psychiatry and Neuropsychology, School of Mental Health and Neuroscience (MHeNS), Maastricht University Medical Centre, Maastricht, the Netherlands.
Bart RuttenDepartment of Psychiatry and Neuropsychology, School of Mental Health and Neuroscience (MHeNS), Maastricht University Medical Centre, Maastricht, the Netherlands.
Jim van OsDepartment of Psychiatry and Neuropsychology, School of Mental Health and Neuroscience (MHeNS), Maastricht University Medical Centre, Maastricht, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrevious studies assessing the hypothesis that the construct of 'aberrant salience' is associated with psychosis and psychotic symptoms showed conflicting results. For this reason, the association between measures to index aberrant salience and subclinical psychotic symptoms in a general population sample was analysed. In addition, genetic vulnerability was added to the analysis as a modifier to test the hypothesis that modification by genetic vulnerability may explain variability in the results.

methodsThe TwinssCan project obtained data from general population twins (N = 887). CAPE (Community Assessment of Psychic Experience) scores were used to index psychotic experiences. Aberrant salience was assessed with white noise task and ambiguous situations task.

resultsMeasures of aberrant salience were not associated with psychotic experiences, nor was there evidence for an interaction with genetic predisposition in this association (Z = 1.08, p = 0.282).

conclusionsVarious studies including the present could not replicate the association between aberrant salience and psychotic experiences in general population samples. The conflicting findings might be explained by moderation by genetic vulnerability, but results are inconsistent. If there was evidence for a main effect or interaction, this was in the positive symptom scale only. On the other hand, the association was more robust in so-called 'ultra-high risk' patients and first episode psychosis patients. Thus, this association may represent a state-dependent association, present only at the more severe end of the psychosis spectrum.

Indexed as

Genetic Predisposition to DiseasePsychotic DisordersAdolescentAdultDiseases in TwinsFemaleHumansMaleMiddle AgedTwinsYoung AdultAberrant salienceGenetic vulnerabilitySubclinical psychotic symptoms

Identifiers

PMID39462331
PMCPMC11515186

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.